Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Capital Growth Systems, Inc. (CGSY.OB) Subsidiary Debuts Telecom Tariff Pricing Information System

QualityStocks (October 22nd, 2009) Writes:

World leader in the telecom information and logistics sector, Global Capacity, Inc. (GC) announced this morning the launch of a new, global tariff pricing system, GCPrice.

GCPrice will give direct access to GC’s massive database of prices and logistical information, allowing customers to scope and range telecom tariffs for Leased Line and Ethernet services in a real-time, high fidelity data environment. This database represents 75 carriers in 67 different countries, inputting over 5,000 discrete tariffs. With geographic and telecom location data points in excess of 10 million, this database represents the most comprehensive quotation development and point-of-sale information aggregating resource available online, capable of generating detailed reports for GC’s customers.

GC has a great deal of experience crafting integrated supply chain management systems and managing complex distributed data architectures, and offers its customers a one-stop-shop approach to telecom information and logistics. This Chicago, IL- based company has operating centers worldwide to

...

DrStockPick.com Stock Report! 9/15/09, LXRX, ALNY, EBAY, EMAN, IM, GELV

Dr. Stock Pick (September 15th, 2009) Writes:

DrStockPick.com Stock Report!

Tuesday September 15, 2009

signup3m

**************************************************************

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2 (SGLT2). LX4211 is Lexicon’s fourth drug candidate currently being tested in Phase 2 clinical trials.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT),

...

PennyOmega.com Stock Report! 9/03/09, CAXG, TK, RFMD, ATK, MOT, ANF

Penny Omega (September 3rd, 2009) Writes:

 

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

signup3m

________________________________________

 

Thursday September 3, 2009

PennyOmega.com Stock Report!

**************************************************************

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) (”China Aoxing”), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral

...

PennyOmega.com Stock Report! 8/18/09, LAZ, UDR, STWG, HD, HILL, DOX

Penny Omega (August 18th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Tuesday August 18, 2009

PennyOmega.com Stock Report!

**************************************************************

Lazard Ltd (NYSE:LAZ) announced today that Tom Tuft, one of the leading bankers in equity capital markets, will join Lazard as Chairman, Global Capital Markets Advisory, and a Vice Chairman, US Investment Banking in November. Mr. Tuft, based in New York, will join Lazard from Goldman Sachs & Co., where he most recently served as Chairman of its Equity Capital Markets group.

UDR, Inc. (NYSE: UDR), a leading multifamily real estate investment trust (REIT), today announced that it has extended the early tender deadline in respect of its previously announced cash tender offer and consent solicitation (the “Offer”) for its

...

Advanced ID Corp. (AIDO.OB) – Capitalizing on Vast Global RFID Market

QualityStocks (August 27th, 2008) Writes:

Advanced ID Corp. (AIDO.OB) is a complete solutions provider in the radio frequency identification (RFID) market. The company provides products for positive identification of both inanimate objects for supply chain applications and companion animals for tracing and recovery purposes.

AIDO uses low frequency radio waves for companion animal recovery and is the 2nd largest player in the Canadian market for these services with an estimated 40% market share. The company is also involved in ultra high frequency RFID for tires. AIDO provides lifetime IDs for tires that can be used for inventory purposes, tire recalls, etc.

AIDO continues to expand its product line. The company’s tracking systems are being tested by major companies in the vehicle ID, pharmaceutical, food services, retail, and document management industries. In addition, the company has introduced two new tire maintenance products that position AIDO as an industry leader in tire diagnostics. Revenues for this business line are

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.